benzomorphans - CISMeF

Preferred Label : benzomorphans;

MeSH definition : Morphine derivatives of the methanobenzazocine family that act as potent analgesics.;

MeSH hyponym : benzomorphan;

MeSH annotation : analgesics;

Is substance : O;

Details

Origin ID

D001575;

UMLS CUI

C0005075;

ATC code(s)
- benzomorphan derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Benzomorphan [ICHI extension code]
Record concept(s)
- benzomorphan [MeSH concept]
- benzomorphans [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2'-heptylcarbamoyloxy-2-methyl-6,7-benzomorphan [MeSH Supplementary Concept]
- 2'-hydroxy-5,9-dimethyl-8,2-epoxyethano-6,7-benzomorphan [MeSH Supplementary Concept]
- 2,5-dimethyl-9 alpha-ethyl-2'-hydroxy-6,7-benzomorphan [MeSH Supplementary Concept]
- 2,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphan [MeSH Supplementary Concept]
- 2-(2-(4-bromoacetamidophenyl)ethyl)-5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphan [MeSH Supplementary Concept]
- 2-benzyl-9-methyl-6,7-benzomorphan [MeSH Supplementary Concept]
- 3-((2R,6R,11R)-8-hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl)-N-phenylpropanamide [MeSH Supplementary Concept]
- 3-chlorallyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan [MeSH Supplementary Concept]
- 5,9 alpha-diethyl-2'-hydroxybenzomorphan [MeSH Supplementary Concept]
- 5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride [MeSH Supplementary Concept]
- 7,8-dihydroxy-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-1-ol [MeSH Supplementary Concept]
- 8-amino-3-((tetrahydro-2-furanyl)methyl) benzomorphan [MeSH Supplementary Concept]
- BIII 277 CL [MeSH Supplementary Concept]
- BIII 890 CL [MeSH Supplementary Concept]
- GPA 1657 [MeSH Supplementary Concept]
- ID 1229 [MeSH Supplementary Concept]
- MR 1353 [MeSH Supplementary Concept]
- MR 2034 [MeSH Supplementary Concept]
- MR 2266 [MeSH Supplementary Concept]
- MRZ 2549 [MeSH Supplementary Concept]
- N-(2,4,5-trihydroxyphenethyl)normetazocine [MeSH Supplementary Concept]
- bremazocine [MeSH Supplementary Concept]
- cogazocine lactate [MeSH Supplementary Concept]
- etazocine [MeSH Supplementary Concept]
- fluorophen [MeSH Supplementary Concept]
- mr 1268 [MeSH Supplementary Concept]
- mr 1452 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- Benzomorphan [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients